PolyPid Ltd. (PYPD)

Last Closing Price: 3.38 (2025-08-28)

Company Description

PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-29.02M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.66
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -453.95%
Return on Assets (Trailing 12 Months) -138.92%
Current Ratio (Most Recent Fiscal Quarter) 2.28
Quick Ratio (Most Recent Fiscal Quarter) 2.28
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $1.29
Earnings per Share (Most Recent Fiscal Quarter) $-0.78
Earnings per Share (Most Recent Fiscal Year) $-4.91
Diluted Earnings per Share (Trailing 12 Months) $-3.83
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 15.90M
Free Float 11.97M
Market Capitalization $54.37M
Average Volume (Last 20 Days) 0.07M
Beta (Past 60 Months) 1.40
Percentage Held By Insiders (Latest Annual Proxy Report) 24.70%
Percentage Held By Institutions (Latest 13F Reports) 26.47%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%